Autopsy report · NCT01779466

Daytime Impact Sleep Study

“Terminated due to lack of eligible patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 1 year 2 months before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Ferring Pharmaceuticals

Sponsor type

Industry

Conditions

Nocturia

Interventions

Desmopressin; Placebo (not active)

Participants

5

Sites

1

Countries

United Kingdom

Trials that died the same way

• Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity
  “terminated after 2 patients due to difficulty in enrollment” (83% match in meaning)
• The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"
  “Study terminated due to lack of eligible patients” (82% match in meaning)
• Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer
  “Terminated due to lack of efficacy” (80% match in meaning)
• Digital Therapeutic vs Educational App for Depression Among Adolescents
  “Terminated due to difficulty enrolling patients in the proposed time frame” (80% match in meaning)
• Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy
  “Terminated due to lack of enrollment” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.